Yüz Doksan Yedi Behçet Hastasının Klinik ve Demografik Özellikleri

Year 2021, Volume: 74 Issue: 1, 60 - 67, 30.04.2021

Didem Rota , Fatma Efsun Tanacan , Oğulcan İbiş Özge Gündüz , Fatma Gülru Erdoğan , Aysel Gürler

https://doi.org/10.4274/atfm.galenos.2021.03371

Abstract

Objectives: We aimed to share our data on Behçet’s disease (BD) collected in the last fourteen years (demographic and clinical characteristics of the patients) and to update our knowledge on BD by comparing it with the results of similar studies conducted in our country.

Materials and Methods: This is a retrospective study conducted by examining the clinical and demographic characteristics of a total 197 patients, including 111 females and 86 males, who were admitted to the Ufuk University Dermatology and Venereal Diseases Polyclinic between January 2006 and January 2020 and who were diagnosed with BD according to the International BD Study Group Criteria (IBSG) and taken into the follow-up system in our BD Center.

Results: One hundred eleven female and eighty-six male patients between the ages of 16 and 65 years were included in the study. The ratio of 10 men/women in patients was 0.77. The mean age of the patients at the time of presentation was 37.38±13.91 years, and the mean age at onset of disease was 27.07±9.77 years. Oral aphthae were observed in 100% of the patients because the IBSG criteria were used. Family history was positive in 20.8%. Genital ulcer was detected in 71%, erythema nodosum in 43.6% and papulopustular lesions in 54.3%. Pathergy test was positive in 42.6% of the patients. Eye involvement was detected in 38.8% of the patients, articular in 21.3%, vascular in 7.6%, gastrointestinal in 0.5% and pulmonary in 1.5%.

Conclusion: BD is a multisystemic disease, morbidity of which can be reduced and mortality of which can be prevented with early diagnosis and treatment. Due to the high prevalence in our country and the fact that it is a disease that requires a multidisciplinary approach, the number of experienced centers that will deal with the disease in every aspect should be increased.

Key Words: Behçet’s Disease, Clinic, Demographic Features

Keywords

Behçet’s Disease , Clinic , Demographic Features

Ethical Statement

-

Supporting Institution

-

Project Number

-

Thanks

-

References

• 1. Gürler A, Boyvat A, Türsen U. Clinical manifestations of Behçet’s disease: an analysis of 2147 patients. Yonsei Med J. 1997;38:423-427.
• 2. Tursen U, Gurler A, Boyvat A. Evaluation of clinical findings according to sex in 2313 Turkish patients with Behçet’s disease. Int J Dermatol. 2003;42:346- 351.
• 3. Azizlerli G, Köse AA, Sarica R, et al. Prevalence of Behçet’s disease in Istanbul, Turkey. Int J Dermatol. 2003;42:803-806.
• 4. Fernández-Ávila DG, Rincón-Riaño DN, Bernal-Macías S, et al. Prevalence and demographic characteristics of Behcet disease in Colombia: data from the national health registry 2012-2016. Rheumatol Int. 2020;40:17-20.
• 5. Demirhindi O, Yazıcı H, Binyıldız P, et al. Silivri Fener Köyü ve yöresinde Behçet hastalığı sıklığı ve bu hastalığın toplum içinde taranmasında kullanılabilecek bir yöntem. Cerrahpaşa Tıp Fak Derg. 1981;12:509-514.
• 6. Yurdakul S, Günaydin I, Tüzün Y, et al. The prevalence of Behçet’s syndrome in a rural area in northern Turkey. J Rheumatol. 1988;15:820-822.
• 7. Idil A, Gürler A, Boyvat A, et al. The prevalence of Behçet’s disease above the age of 10 years. The results of a pilot study conducted at the Park Primary Health Care Center in Ankara, Turkey. Ophthalmic Epidemiol. 2002;9:325- 331.
• 8. Cakir N, Dervis E, Benian O, et al. Prevalence of Behçet’s disease in rural western Turkey: a preliminary report. Clin Exp Rheumatol. 2004;22:53-55.
• 9. Çölgeçen E, Özyurt K, Ferahbaş A, et al. The prevalence of Behçet’s disease in a city in Central Anatolia in Turkey. Int J Dermatol. 2015;54:286-289.
• 10. Criteria for diagnosis of Behçet’s disease. International Study Group for Behçet’s Disease. Lancet. 1990;335:1078-1080.
• 11. Alpsoy E, Donmez L, Onder M, et al. Clinical features and natural course of Behçet’s disease in 661 cases: a multicentre study. Br J Dermatol. 2007;157:901-906.
• 12. Davatchi F, Chams-Davatchi C, Shams H, et al. Behcet’s disease: epidemiology, clinical manifestations, and diagnosis. Expert Rev Clin Immunol. 2017;13:57-65.
• 13. Uslu M, Karaman G, Savk E, et al. Aydın’da Behçet Hastalığı Deneyimi 67 Hastanın retrospektif Değerlendirmesi. ADÜ Tıp Fakültesi Dergisi 2008;9:21-26.
• 14. Gündüz Ö, Gürler A, Ayanoglu BT, et al. Ufuk Üniversitesi Behçet Hastalığı Merkezinde Takip Edilen Behçet Hastalarının Epidemiyolojik Özellikleri. Turkiye Klinikleri J Dermatol. 2015;25:85-91.
• 15. Balta I, Akbay G, Kalkan G, et al. Demographic and clinical features of 521 Turkish patients with Behçet’s disease. Int J Dermatol. 2014;53:564-569.
• 16. Alpsoy E. Behçet Hastalığı: Epidemiyoloji. Turkiye Klinikleri J Dermatol- Special Topics. 2017;10:265-270.
• 17. Ceylan Kalın Z, Sarıcaoğlu H, Yazici S, et al. Clinical and Demographical Characteristics of Familial Behçet’s Disease (Southeast Marmara Region). Dermatology. 2019;235:407-412.
• 18. Borlu M, Ukşal U, Ferahbaş A, et al. Clinical features of Behçet’s disease in children. Int J Dermatol. 2006;45:713-716.
• 19. Karabacak E, Dogan B, Goker K, et al. Behçet hastalığı: 182 hastanın klinik ve demografik özellikleri. Türkderm. 2014;48:121-126.
• 20. Sula B, Batmaz I, Ucmak D, et al. Demographical and Clinical Characteristics of Behcet’s Disease in Southeastern Turkey. J Clin Med Res. 2014;6:476-481.
• 21. Ugurlu N, Bozkurt S, Bacanli A, et al. The natural course and factors affecting severity of Behçet’s disease: a single-center cohort of 368 patients. Rheumatol Int. 2015;35:2103-2107.
• 22. Boyvat A. Behçet Hastalığında Deri ve Mukoza Belirtileri. Türkderm. 2009;43:42-47.
• 23. Boyvat A. Behçet Hastalığında Tanı ve Ayırıcı Tanı. Turkiye Klinikleri J Dermatol-Special Topics. 2017;10:315-320.
• 24. Alpsoy E, Zouboulis CC, Ehrlich GE. Mucocutaneous lesions of Behcet’s disease. Yonsei Med J. 2007;48:573-85. 25. Alpsoy E. Behçet Hastalığının Deri ve Mukoza Belirtileri. Türkderm. 2003;37:92-99.
• 26. Yazici H, Tüzün Y, Pazarli H, et al. Influence of age of onset and patient’s sex on the prevalence and severity of manifestations of Behçet’s syndrome. Ann Rheum Dis. 1984;43:783-789.
• 27. Erdem C, Gürler A, Kundakçı N. Behçet hastalarında üç aşamalı paterji testi ile elde edilen sonuçlar. Lepr Mec. 1987;18:73-84. [Google Scholar]
• 28. Kalay Yildizhan İ, Boyvat A. Diagnostic Sensitivity of Different Applications of Pathergy Test for Behçet’s Disease. Arch Rheumatol. 2019;35:29-34.
• 29. Evereklioglu C, Düzgün B. Behçet Hastalığı’nda Göz Tutulumu. Turkiye Klinikleri J Dermatol-Special Topics. 2017;10:283-238.
• 30. Yildirim A, Senel AS. Kas ve Eklem Bulguları. Turkiye Klinikleri J Dermatol- Special Topics. 2017;10:289-292.
• 31. Calgüneri M, Kíraz S, Ertenli I, et al. Characteristics of peripheral arthritis in Behçet’s disease. N Z Med J. 1997;110:80-81.
• 32. Erkan F, Gül A, Tasali E. Pulmonary manifestations of Behçet’s disease. Thorax. 2001;56:572-578.
• 33. Ozcan OU, Gürlek A, Yıldız G, et al. Management of Pulmonary Artery Aneurysm and Intracardiac Thrombus in a Young Male With Behçet’s Disease. Arch Rheumatol. 2014;29:318-320.
• 34. Tamer F, Gülru Erdoğan F, Dinçer Rota D, et al. Multiorgan involvement of Behçet’s disease in a young woman. Acta Dermatovenerol Alp Pannonica Adriat. 2018;27:153-154.
• 35. Karincaoglu Y, Coskun BK, Seyhan M, et al. Demographical and Clinical Characteristics of Behcet’s Disease Patients in Malatya and Elazig. Turkiye Klinikleri J Dermatol. 2005;15:65-70.